High-dimensional mass cytometry reveals systemic and local immune signatures in necrotizing enterocolitis

Front Immunol. 2023 Nov 17:14:1292987. doi: 10.3389/fimmu.2023.1292987. eCollection 2023.

Abstract

Objective: Patients with necrotizing enterocolitis display severe gastrointestinal complications of prematurity, but the mechanism driving this clinical profile remains unknown. We used mass cytometry time-of-flight to characterize and compare immune cell populations in the blood and intestine tissue from patients with and without (controls) necrotizing enterocolitis at single-cell resolution.

Methods: We completed a deep mapping of the immune system of the peripheral blood mononuclear cells and intestinal mucosa tissue using mass cytometry to evaluate immune cell types, which revealed global immune dysregulation characteristics underlying necrotizing enterocolitis.

Results: Compared with controls, natural killer cells display signs of heightened activation and increased cytotoxic potential in the peripheral blood and mucosa of patients with necrotizing enterocolitis. Furthermore, CD4+ T effector memory cells, non-classical monocytes, active dendritic cells, and neutrophils were specifically enriched in the mucosa, suggesting trafficking from the periphery to areas of inflammation. Moreover, we mapped the systemic and local distinct immune signatures suggesting patterns of cell localization in necrotizing enterocolitis.

Conclusion: We used mass cytometry time-of-flight technology to identify immune cell populations specific to the peripheral blood and intestinal mucosa tissue from patients with necrotizing enterocolitis and controls. This information might be used to develop precise diagnosis and therapies that target specific cell populations in patients with necrotizing enterocolitis.

Keywords: immune dysregulation; mass cytometry; mucosal immunity; necrotizing enterocolitis; neonate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enterocolitis, Necrotizing*
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Infant, Premature
  • Intestinal Mucosa
  • Intestines
  • Leukocytes, Mononuclear / metabolism

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funds to YL: National Natural Science Foundation of China (8217060280); Guangdong Basic and Applied Basic Research Foundation (2114050002084); Science and Technology Project in Guangzhou (202102020387); Guangdong Medical Science and Technology Research Fund (A2020186); Funds to SL: National Natural Science Foundation of China (82271736); Guangdong Basic and Applied Basic Research Foundation (2021A1515010593); Funds to YC: The Medical Research Foundation of Guangdong Province (2022066); National Key Clinical Discipline; Program of Guangdong Provincial Clinical Research Center for Digestive Diseases (2020B1111170004).